Remove FDA Approval Remove Information Remove Nurses
article thumbnail

DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

The Pharma Data

Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth. “This pediatric approval for DALVANCE as a single-dose provides a meaningful contribution to the treatment of children and infants with ABSSSI.”

article thumbnail

The Long Road to End Tuberculosis

Codon

These challenges have led to strategies such as directly observed therapy (DOT), in which nurses or physicians monitor patients to ensure they take their medicine every day. Nurses meet with patients daily, in person, or — in areas with electricity and access to technology — watch them take their pills via an online video call.

Vaccine 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dentitox Pro – Text Presentation

The Pharma Data

The product is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards. After you fill in your information and confirm your package will be shipped for free right to your doorstep as soon as possible. Dentitox Pro is non-GMO and safe.

article thumbnail

DermaPrime

The Pharma Data

Every capsule is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards. After you fill in your information and confirm your order, your bottle of DermaPrime Plus will be shipped for free right to your doorstep as soon as possible.

article thumbnail

FDA Set to Approve Pfizer’s COVID Vaccine

The Pharma Data

Health care workers and nursing home residents and staff should get the first shots, according to guidelines issued recently by the U.S. Further Support and Information on COVID-19. Centers for Disease Control and Prevention. Initially, a shipment of 2.9 That is only about half of the doses that have been prepared so far.

Vaccine 52
article thumbnail

Regeneron’s Casirivimab and Imdevimab Antibody Cocktail for COVID-19 is First Combination Therapy to Receive FDA Emergency Use Authorization

The Pharma Data

Health care providers should review the Fact Sheet for detailed information on the authorized use and requirements of the EUA and may call 844-734-6643 for more information. Please see the Fact Sheet and FDA Letter of Authorization at [link]. AUTHORIZED USE AND IMPORTANT SAFETY INFORMATION. Authorized Emergency Use.

article thumbnail

BioXcel Therapeutics Receives FDA Clearance of IND for Phase 2 Trial with BXCL501 for the Treatment of Agitation Associated with DeliriumFifth potential indication for BXCL501, an orally dissolving thin film

The Pharma Data

“We are pleased to continue pursuing additional neuroscience opportunities with BXCL501, targeting agitation associated with delirium, a fifth potential indication for this candidate and a condition for which there is no FDA-approved treatment,” commented Vimal Mehta, Chief Executive Officer of BTI. Forward-Looking Statements.